We are live on ! Find out more
LP

Longaeva Partners Portfolio holdings

AUM $2.7B
1-Year Est. Return 37.16%
This Fund
S&P 500
This Quarter Est. Return
+15.15%
1 Year Est. Return
+37.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$490M
AUM Growth
+$313M
Cap. Flow
+$275M
Cap. Flow %
56.08%
Top 10 Hldgs %
58.34%
Holding
57
New
36
Increased
7
Reduced
10
Closed
3

Top Buys

Rank Stock Value
1
CAI
Caris Life Sciences
CAI
+$39.3M
2
BRO icon
Brown & Brown
BRO
+$25.3M
3
EW icon
Edwards Lifesciences
EW
+$19.2M
4
QXO
QXO Inc
QXO
+$19.1M
5
BIRK icon
Birkenstock
BIRK
+$18.9M

Sector Composition

Rank Sector Weight
1 Healthcare 26.24%
2 Financials 18.92%
3 Consumer Discretionary 14.37%
4 Industrials 11.18%
5 Technology 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KNTK icon
51
Kinetik
KNTK
$3.71B
$418K 0.09%
+9,481
New +$416K
KARO icon
52
Karooooo
KARO
$1.96B
$245K 0.05%
+4,999
New +$236K
NPCE icon
53
Neuropace
NPCE
$505M
$122K 0.02%
10,933
-89,052
-89% -$1.11M
TRVI icon
54
Trevi Therapeutics
TRVI
$2.49B
$54.7K 0.01%
+10,000
New +$62.2K
ADT icon
55
ADT
ADT
$5.16B
-1,225,151
Closed -$9.97M
AEP icon
56
American Electric Power
AEP
$73.7B
-150,000
Closed -$16.4M
ETR icon
57
Entergy
ETR
$54.1B
-200,000
Closed -$17.1M

Similar funds

Longaeva Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Longaeva Partners held 57 positions worth $490M, up 177% from $177M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Longaeva Partners deployed $275M of net new capital in Q2 2025, opening 36 new positions and adding to 7 existing holdings. Its largest new stake was Caris Life Sciences: 1,459,745 shares worth $39M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Charles Schwab, an estimated $40.2M trimmed.

  • Longaeva Partners's largest Q2 2025 buy was Caris Life Sciences: 1,459,745 shares worth $39M.
  • Longaeva Partners added most to BrightSpring Health Services in Q2 2025, an estimated $14.8M increase.
  • Longaeva Partners's biggest Q2 2025 reduction was Charles Schwab, cutting an estimated $40.2M.
  • Longaeva Partners fully exited Entergy in Q2 2025, selling an estimated $17.1M.
  • Longaeva Partners's ten largest holdings make up 58% of its $490M portfolio in Q2 2025.
  • Longaeva Partners opened 36 new positions and closed 3 in Q2 2025.
  • Longaeva Partners's portfolio value rose 177% quarter-over-quarter to $490M.

Based on Longaeva Partners's 13F filing for Q2 2025, filed 14 Aug 2025.